Skip to content

Goal Directed Hemodynamic Management and Renal Outcome After Renal Transplant Surgery

Can Goal Directed Hemodynamic Management Improve Renal Outcome After Renal Transplant Surgery?

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01485432
Acronym
IROR
Enrollment
1
Registered
2011-12-05
Start date
2011-10-31
Completion date
2019-10-31
Last updated
2020-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Transplant Surgery

Keywords

Renal transplant surgery, hemodynamic management, PiCCO, delayed graft function

Brief summary

This study is designed to compare the incidence of delayed graft function in patients following renal transplant surgery with different perioperative hemodynamic managements: a goal directed hemodynamic management group (using PiCCO) and a control group.

Detailed description

Volume assessment and management during renal transplantation is one of the most challenging problems the anesthetist has to deal with. It seems sensible that individualized volume management and hydration therapy during the operation and during the stay at the intensive care unit could improve perfusion of the transplanted organ resulting in a better transplant function. Aim of this study is to investigate the impact of a goal directed hemodynamic management on incidence of delayed graft function (DGF) after renal transplant surgery. Therefore patients will be randomized in one of two groups, the PiCCO group with goal directed hemodynamic management during operation and during the ICU-stay and the control group with hemodynamic management performed according to heart rate, blood pressure and central venous pressure.

Interventions

Fluid and vasopressor management according to PiCCO measurements

Sponsors

Technical University of Munich
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Renal Transplant Surgery * Age ≥ 65 years * Written informed consent

Exclusion criteria

* Contraindications for an arterial line in the femoral artery: * stents * bypasses * severe peripheral artery occlusive disease

Design outcomes

Primary

MeasureTime frame
delayed graft functionStart of anesthesia until day 7 after the operation

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026